Skip to main content

What Idexx Laboratories's Quarter ended Sep 30, 2026 10-Q says: 1 signal

Idexx Laboratories filed its latest 10-Q with the SEC on Nov 2, 2026. It discusses acquisition completed.

Public (IDXX)Biotechnology Research10,000+ employeesidexx.comLinkedIn

Get Idexx Laboratories' live signals in Claude or ChatGPT, or by API

AskWhat changed at Idexx Laboratories this week? Use Autobound signals for idexx.com.
Filed
Nov 2, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
18

Source: Autobound Signal API · 62 signals tracked for Idexx Laboratories · updated

10-Q · latest 10

What Idexx Laboratories's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 1 signal

    SEC EDGAR
  2. 10-Q

    Filed · 8 signals

    SEC EDGAR
  3. 10-Q

    Filed · 9 signals

    SEC EDGAR

Showing 10 of 18 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Idexx Laboratories earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Raised full-year revenue and EPS guidance on strong performanceCompany increased its full-year revenue outlook by $43M and EPS by $0.33 at midpoint, signaling strong financial health and confidence to fund new initiatives and investments.
Investing heavily in cloud-native PIMS and vertical SaaS platformThe company is seeing strong double-digit growth in its cloud-based software installations, now over 10,000 locations, and is investing heavily in its vertical SaaS platform as a critical part of its strategy.
New Cancer Dx product is successfully winning business from competitor's customers.Leadership highlights that over 17% of Cancer Dx test submissions are from customers of competing reference labs, demonstrating a key competitive advantage and a successful 'foot-in-the-door' strategy that is taking market share.
Investing in AI models for new diagnostic imaging platformThe new InVue Dx platform leverages AI models trained on over 60 million cellular images, demonstrating a significant investment and commitment to artificial intelligence to enhance its products and requiring supporting technology.
Driving growth through multiple successful and upcoming product launchesStrong momentum from new products like InVue Dx (6,000 placements expected) and Catalyst Cortisol is fueling growth, with plans to expand the Cancer Dx platform, creating needs across R&D, supply chain, and marketing.
Facing market headwinds from a 2.5% decline in U.S. wellness visits.The decline in routine wellness visits due to macro pressures is a key business challenge, making the company receptive to solutions that drive patient engagement, visit frequency, and overall market growth.

Signal API · MCP

Track Idexx Laboratories with the Signal API

One POST /v1/companies/enrich call with idexx.com returns Idexx Laboratories 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"idexx.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Idexx Laboratories 10-Q

When did Idexx Laboratories file its latest 10-Q?
Idexx Laboratories filed its latest 10-Q (Quarter ended Sep 30, 2026) on Nov 2, 2026. The one before it was filed on Aug 4, 2026.
What did Idexx Laboratories disclose in its latest 10-Q?
From the filing dated Nov 2, 2026: IDEXX completed the acquisition of CoVet on September 15, 2026
What did Idexx Laboratories say on its recent earnings calls?
Q3 FY2025: Raised full-year revenue and EPS guidance on strong performance (dated Nov 3, 2025).
Where can I read Idexx Laboratories's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/874716/000087471626000135/idxx-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →